ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 186 filers reported holding ADMA BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $28,868,269 | +217839.5% | 2,582,135 | +28.7% | 0.05% | +133.3% |
Q1 2024 | $13,246 | +177.0% | 2,007,035 | +89.7% | 0.02% | +200.0% |
Q4 2023 | $4,782 | -4.4% | 1,057,935 | -24.2% | 0.01% | -22.2% |
Q3 2023 | $5,000 | +11.6% | 1,396,555 | +15.1% | 0.01% | +50.0% |
Q2 2023 | $4,479 | +39.1% | 1,213,735 | +24.7% | 0.01% | +50.0% |
Q1 2023 | $3,221 | +19.3% | 973,235 | +39.8% | 0.00% | 0.0% |
Q4 2022 | $2,700 | -99.8% | 695,935 | +9.0% | 0.00% | +100.0% |
Q3 2022 | $1,551,000 | +8.0% | 638,400 | -12.0% | 0.00% | 0.0% |
Q2 2022 | $1,436,000 | +49.0% | 725,500 | +37.7% | 0.00% | +100.0% |
Q1 2022 | $964,000 | +95.9% | 526,700 | +51.0% | 0.00% | 0.0% |
Q4 2021 | $492,000 | +85.0% | 348,900 | +48.5% | 0.00% | – |
Q3 2021 | $266,000 | -5.3% | 235,000 | +33.8% | 0.00% | – |
Q2 2021 | $281,000 | -76.0% | 175,626 | -6.7% | 0.00% | -100.0% |
Q3 2018 | $1,169,000 | +785.6% | 188,300 | +544.9% | 0.00% | – |
Q2 2018 | $132,000 | +109.5% | 29,200 | +43.8% | 0.00% | – |
Q3 2017 | $63,000 | +50.0% | 20,300 | +79.6% | 0.00% | – |
Q2 2017 | $42,000 | – | 11,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 33,169,604 | $53,072,000 | 0.34% |
Clearline Capital LP | 922,517 | $1,476,000 | 0.22% |
GSA CAPITAL PARTNERS LLP | 860,911 | $1,377,000 | 0.16% |
Prosight Management, LP | 115,100 | $184,000 | 0.12% |
Banco BTG Pactual S.A. | 92,500 | $148,000 | 0.10% |
Meridian Wealth Management, LLC | 164,000 | $262,000 | 0.03% |
Shay Capital LLC | 159,614 | $255,000 | 0.03% |
Signature Wealth Management Partners, LLC | 10,500 | $17,000 | 0.02% |
XTX Topco Ltd | 24,881 | $40,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 227,469 | $364,000 | 0.01% |